Association of SLC32A1 Missense Variants With Genetic Epilepsy With Febrile Seizures Plus

SE Heron; BM Regan; RV Harris; AE Gardner; MJ Coleman; MF Bennett; BE Grinton; KL Helbig; MR Sperling; S Haut; EB Geller; P Widdess-Walsh; JT Pelekanos; M Bahlo; S Petrovski; EL Heinzen; MS Hildebrand; MA Corbett; IE Scheffer; J Gécz; SF Berkovic

Journal article

Association of SLC32A1 Missense Variants With Genetic Epilepsy With Febrile Seizures Plus

SE Heron, BM Regan, RV Harris, AE Gardner, MJ Coleman, MF Bennett, BE Grinton, KL Helbig, MR Sperling, S Haut, EB Geller, P Widdess-Walsh, JT Pelekanos, M Bahlo, S Petrovski, EL Heinzen, MS Hildebrand, MA Corbett, IE Scheffer, J Gécz Show all

Neurology | LIPPINCOTT WILLIAMS & WILKINS | Published : 2021

DOI: 10.1212/WNL.0000000000011855

Abstract

Objective: To identify the causative gene in a large unsolved family with genetic epilepsy with febrile seizures plus (GEFS+), we sequenced the genomes of family members, and then determined the contribution of the identified gene to the pathogenicity of epilepsies by examining sequencing data from 2,772 additional patients. Methods: We performed whole genome sequencing of 3 members of a GEFS+ family. Subsequently, whole exome sequencing data from 1,165 patients with epilepsy from the Epi4K dataset and 1,329 Australian patients with epilepsy from the Epi25 dataset were interrogated. Targeted resequencing was performed on 278 patients with febrile seizures or GEFS+ phenotypes. Variants were v..

View full abstract

University of Melbourne Researchers

Rebekah Harris Author

Matt Coleman Author

Mark Bennett Author

Bronwyn Grinton Author

Related Projects (2)

HUMAN EPILEPSY: UNDERSTANDING BIOLOGY TO IMPROVE OUTCOMES

Our team of neurologists, molecular geneticists, physiologists and brain imaging specialists and leads the world in the discovery of the gen..

IMPLEMENTING PRECISION MEDICINE IN EPILEPSY

I aim to understand the genetics of the epilepsies. Through detailed analysis of different types of epilepsy, and associated features such a..

Grants

Awarded by National Institutes of Health

Funding Acknowledgements

This work was supported by grants from the National Health and Medical Research Council of Australia: Program Grant 1091593 to S.F.B., I.E.S., and J.G.; Career Development Fellowship 1085984 to S.E.H.; Senior Research Fellowship 1102971 to M.B.; and Senior Practitioner Fellowship 1104831 to I.E.S. Additional funding was provided by the Independent Research Institute Infrastructure Support Scheme and the Victorian State Government Operational Infrastructure Program.